![Amersin Life Sciences Corp](/news-release/logo/215053/0/215053.jpg?lastModified=12%2F10%2F2016%2006%3A48%3A43&size=2)
Amersin Appoints Director
17 nov. 2005 12h21 HE
|
Amersin Life Sciences Corp.
NEW YORK, Nov. 17, 2005 (PRIMEZONE) -- Amersin Life Science Corporation (OTCBB:AMLS) (Frankfurt:HUQ) is pleased to announce the immediate appointment of Mr. Rob Gillingham to its Board of...
![Amersin Life Sciences Corp](/news-release/logo/215053/0/215053.jpg?lastModified=12%2F10%2F2016%2006%3A48%3A43&size=2)
Amersin Enters Into Termination Agreement With Chinese Joint Venture Partner
20 oct. 2005 16h30 HE
|
Amersin Life Sciences Corp.
NEW YORK, Oct. 20, 2005 (PRIMEZONE) -- Amersin Life Science Corporation (OTCBB:AMLSE) announced today that it has reached a termination agreement and will be disposing of its interest in the Hubei...
![Amersin Life Sciences Corp](/news-release/logo/215053/0/215053.jpg?lastModified=12%2F10%2F2016%2006%3A48%3A43&size=2)
Amersin Notifies Chinese Joint Venture That it Will Not be Providing Additional Funds
15 sept. 2005 17h56 HE
|
Amersin Life Sciences Corp.
NEW YORK, Sept. 15, 2005 (PRIMEZONE) -- Amersin Life Science Corporation (OTCBB:AMLS) Chief Executive Officer, H.Y. (Reid) Li, announced that the company notified the minority partners in its Hubei...
![Amersin Life Sciences Corp](/news-release/logo/215053/0/215053.jpg?lastModified=12%2F10%2F2016%2006%3A48%3A43&size=2)
Amersin Announces Delay in Filing Annual Report Due to Auditor's Workload
18 mai 2005 09h30 HE
|
Amersin Life Sciences Corp.
NEW YORK, May 18, 2005 (PRIMEZONE) -- Amersin Life Science Corporation (OTCBB:AMLS) announced today that delays resulting from workload in the office of its auditors, Moen and Company, will result in...
![Amersin Life Sciences Corp](/news-release/logo/215053/0/215053.jpg?lastModified=12%2F10%2F2016%2006%3A48%3A43&size=2)
Amersin Subsidiary Makes Application to State Food and Drug Administration For New Antiviral Drug License
12 mai 2005 10h38 HE
|
Amersin Life Sciences Corp.
NEW YORK, May 12, 2005 (PRIMEZONE) -- Amersin Life Science Corporation (OTCBB:AMLS) announced today that its subsidiary, Hubei Tongji Benda Ebei Pharmaceutical Co. (Hubei Benda), has applied to the...
![Amersin Life Sciences Corp](/news-release/logo/215053/0/215053.jpg?lastModified=12%2F10%2F2016%2006%3A48%3A43&size=2)
Amersin Subsidiary Receives 30 Million RMB Contract
06 avr. 2005 09h00 HE
|
Amersin Life Sciences Corp.
NEW YORK, April 6, 2005 (PRIMEZONE) -- Amersin Life Science Corporation (OTCBB:AMLS) announced today that its subsidiary, Hubei Tongji Benda Ebei Pharmaceutical Company, has been awarded a 30 million...
![Amersin Life Sciences Corp](/news-release/logo/215053/0/215053.jpg?lastModified=12%2F10%2F2016%2006%3A48%3A43&size=2)
Amersin Life Science Announces Appointment of Director
01 mars 2005 14h10 HE
|
Amersin Life Sciences Corp.
NEW YORK, March 1, 2005 (PRIMEZONE) -- Amersin Life Science Corporation (OTCBB:AMLS), is pleased to announce the appointment Mr. (Harry) Zhihao Jin to its board of directors.
Mr. Harry Jin served...
![Amersin Life Sciences Corp](/news-release/logo/215053/0/215053.jpg?lastModified=12%2F10%2F2016%2006%3A48%3A43&size=2)
Amersin Announces 30% Increase in Ribavirin Production to Meet Market Demand Following Recent Avian Flu Outbreaks in Asia
31 janv. 2005 06h00 HE
|
Amersin Life Sciences Corp.
NEW YORK, Jan. 31, 2005 (PRIMEZONE) -- Amersin Life Sciences Corporation (OTCBB:AMLS) announced today that its subsidiary, Hubei Tongji Benda Ebei Pharmaceutical Co. Ltd. (HBPharma), will increase...
![Amersin Life Sciences Corp](/news-release/logo/215053/0/215053.jpg?lastModified=12%2F10%2F2016%2006%3A48%3A43&size=2)
Hubei Pharmaceutical Group Reports Second Quarter Operational Profit of $681,666
23 sept. 2004 09h00 HE
|
Amersin Life Sciences Corp.
NEW YORK, Sept. 23, 2004 (PRIMEZONE) --
---------------------------------------------------------------------
Operational Results Second Quarter Six Months
at a Glance ...
![Amersin Life Sciences Corp](/news-release/logo/215053/0/215053.jpg?lastModified=12%2F10%2F2016%2006%3A48%3A43&size=2)
Hubei Pharmaceutical Group to Sell Joint Venture Interest
14 sept. 2004 13h09 HE
|
Amersin Life Sciences Corp.
NEW YORK, Sept. 14, 2004 (PRIMEZONE) -- Hubei Pharmaceutical Group (OTCBB:HBEI) filed notice with the SEC today that it will sell its joint venture interest in Hubei Pharmaceutical Co. Ltd....